Glen Lutchman

Back to Profile

Publication Details

  • Pilot study of interferon gamma for chronic hepatitis C.

    Soza A, Heller T, Ghany M, Lutchman G, Jake Liang T, Germain J, Hsu HH, Park Y, Hoofnagle JH. J Hepatol. 2005; 43 (1): 67-71

    Currently, there are no effective therapies available for patients with chronic hepatitis C who have failed to respond to optimal interferon alfa-based regimens. The aims of this pilot study were to assess the antiviral activity and safety of interferon gamma in chronic hepatitis C.

    PubMedID: 15913831

Stanford Medicine Resources:

Footer Links: